Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.025% in pediatric myopia progression
NCT07329777Phase 3Recruiting
- Sponsor
- IDB VisionCare
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myopia comparing Atropine Sulphate 0.025% w/v Eye Drops with Placebo (2 arms). Primary endpoint: Spherical equivalent at 12 months. Started Sep 2025; status: recruiting.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07329777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07329777.